Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: CASI PHARMACEUTICALS INC(CASIF) the Revenue is 4.909 M (+17.57%);the EBIT is -8.219 M (+23.26%);the EPS is -0.487 (+43.51%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B17.57%
----
----
EBIT
-0.01B23.26%
----
----
EPS
-0.487343.51%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf